用日本药物不良事件报告数据库对心理药物诱导尿的药监测研究
Shusuke Uekusa1, Keika Mogi2, Yuki Ota2
1Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba, 274-8510, Japan. shuusuke.uekusa@phar.toho-u.ac.jp.
Drugs - real world outcomes
|November 13, 2024
概括
许多精神药物可以导致尿路滞留 (UR),特别是在老年患者和患有良性前列腺增生或抑郁症的患者中. 监测至关重要,特别是对于具有危险因素的个体.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 药品安全 药品安全
背景情况:
- 众所周知,精神药物可以通过抗胆固醇和其他机制引起尿 (UR).
- 由于其非致命的症状,UR经常被忽视,因此需要进一步调查其与精神药物使用的关联.
研究的目的:
- 调查与使用精神药物相关的尿 (UR) 的发生情况.
- 确定增加UR风险的特定精神药物.
主要方法:
- 利用日本药物不良事件报告 (JADER) 数据库分析了74种精神药物.
- 计算了UR的报告几率 (ROR) 并使用多变量逻辑回归来调整性别,年龄,良性前列腺增生 (BPH) 和抑郁症.
主要成果:
- 在报告的887704个病例中,4653个 (0.52%) 涉及UR.
- 在老年患者 (≥60岁),男性和患有BPH或抑郁症的患者中,UR更为普遍.
- 信号检测确定了38种精神药物,调整后的RORs表明UR风险增加,这些药物包括奎平,普罗马зин,埃蒂佐拉姆,马普罗提林,米尔塔扎平和杜洛丁.
结论:
- 相当数量的精神药物与诱导UR有关,可能是由于它们的药理性质.
- 建议对UR进行密切监测,特别是在患有先前存在的风险因素,如晚年,BPH或抑郁症的患者中.
相关概念视频
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
87
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
87
Drugs Affecting Neurotransmitter Release or Uptake
954
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
954
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
182
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
182
Drug Elimination by Renal Route: Tubular Reabsorption
3.2K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.2K


